Geant4-DNA 2016 Collaboration Meeting

Europe/Paris
Building A3

Building A3

Sébastien Incerti (CNRS/IN2P3/CENBG)
Description

This year, the Geant4-DNA annual Collaboration Meeting will be hosted by the Centre de Recherche en Cancérologie de Toulouse, Paul Sabatier University in Toulouse, France. The meeting is open to Geant4-DNA collaboration members only.

The meeting will take place at the Faculté de Médecine Rangueil, 133 Route de Narbonne, 31400 Toulouse, France, see the map at this link. There is free car parking at this address. In addition, this place is close to the "Université Paul Sabatier" Metro B line stop (line B, direction: Ramonville, from Toulouse city center). 

The meeting will take place in building A3 ("Biophysics" building) at floor level (please follow signs).

Participants may stay in Toulouse city center hotels, close to metro subway stations (for example, hotels can be found on the AccorHotels web site).

Please kindly inform well in advance Marie-claude Bordage (marie-claude.bordage@inserm.fr) and S. Incerti (incerti@cenbg.in2p3.fr) about your participation, about the talk you wish to present (title, duration) and whether you need a WiFi access. Alternatively, participants are suggested to enable their Eduroam WiFi access on their own laptop.

Thank you.


We look forward to welcoming you in Toulouse !

    • 1
      Welcome
    • 2
      Geant4-DNA cross section models for NP
      Orateur: Dr Dousatsu Sakata
    • 3
      Geant4-DNA for bacteria irradiation simulations
      Orateur: M. Nathanel Lampe
    • 4
      Wollongong U. activities
      Orateur: Dr Susanna Guatelli
    • 5
      Geant4-DNA CPA100 models
      Orateur: M. Julien Bordes
    • 6
      IRSN activities
      Orateur: Dr Carmen Villagrasa (IRSN)
    • 7
      Geant4-DNA manpower & task list
      Orateur: Dr Sébastien Incerti (CNRS/IN2P3/CENBG)
    • 12:00
      Lunch break
    • 8
      Campinas U. activities
      Orateur: Dr Mario Bernal
    • 9
      JINR activities
      Orateur: Dr Oleg Belov
    • 10
      General Discussion
    • 11
      Steering Committee meeting